One in five women experiences pain during intercourse, yet most never tell a doctor. Dyspareunia—the clinical term for this condition—remains one of medicine's most common but least diagnosed sexual dysfunctions, a gap rooted not in medical uncertainty but in shame, taboo, and fragmented care.
The scale of the problem is striking. According to analysis published in the Journal of Clinical Medicine, around 20% of women experience symptoms of dyspareunia. Yet this prevalence masks a deeper reality: many women suffer in silence for years, their pain invisible to the health care system because they never report it. The condition isn't rare or exotic—it's simply treated as unspeakable.
Dr. Hab. Marek Murawski from the Department of Operative Gynecology and Oncology at Wroclaw Medical University points to the fundamental challenge: dyspareunia is genuinely multidimensional. Physical causes matter—endometriosis, pelvic inflammatory conditions, hormonal deficiencies—but psychological and social factors are equally important. Yet medicine often approaches it with a narrowly biomedical lens. "It is not uncommon to observe doctors focusing exclusively on the biomedical approach, completely overlooking the functional and psychological aspects," Murawski explains. The result is that some women receive a diagnosis while the actual root cause remains hidden.
Shame acts as a diagnostic barrier. Despite dyspareunia's significant impact on intimate relationships, it remains taboo in many clinical settings and in broader society. This stigma doesn't just isolate patients—it actively delays diagnosis. The doctor-patient relationship becomes crucial. Whether a woman feels safe enough to speak about her symptoms depends entirely on the quality of that conversation. As Murawski emphasizes, "A detailed medical history, including psychological and sexological aspects, seems to be a key element in enabling the correct diagnosis."
The path forward exists but remains fragmented. Effective treatment requires genuine multidisciplinary collaboration: gynecologists working alongside urogynecological physiotherapists, psychologists, and sexologists. Evidence increasingly supports pelvic floor physiotherapy as an effective first-line treatment, while cognitive-behavioral therapy reduces anxiety linked to pain. Comprehensive care integrates pharmacotherapy, physiotherapy, sexual education, and psychotherapy. Yet access remains limited, especially within public health systems.
The irony is sharp: the greatest barrier to progress is not lack of medical knowledge. Dyspareunia is described in medical literature, its mechanisms are partially understood, and treatment methods are available. What's missing is application—the systems, training, and cultural shift needed to bring this knowledge to those who need it. Thousands of women continue to experience preventable suffering because the condition remains invisible in clinical practice.
The first step toward change, then, is deceptively simple: recognizing that pain during intercourse is not normal, not something to endure silently, but a real medical and psychological problem worthy of attention, diagnosis, and compassionate, integrated care.